Skip to main navigation Skip to search Skip to main content

Daily PrEP and event-driven PrEP adherence for men who have sex with men in China

  • Fei Teng
  • , Paul A. Burns
  • , Michael A. Welsch
  • , Benjamin Walker
  • , Ke Liang
  • , Haojie Huang
  • , Zhuoheng Yin
  • , Linghua Li
  • , Chunyan Li
  • , Renslow Sherer
  • , Aniruddha Hazra
  • , Jonathan Lio
  • , Danwen Qiu
  • , Joseph D. Tucker
  • , Weiming Tang*
  • *Corresponding author for this work
  • University of Mississippi
  • Zhongnan Hospital Wuhan University
  • Wuhan Tongxing LGBT Center
  • University of North Carolina Project-China
  • Guangzhou Eighth People’s Hospital
  • The University of Tokyo
  • The University of Chicago
  • Gilead Sciences
  • University of North Carolina at Chapel Hill
  • Southern Medical University
  • London School of Hygiene and Tropical Medicine

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The HIV incidence among Chinese men who have sex with men (MSM) has still been high over the past decade. Despite HIV pre-exposure prophylaxis (PrEP) being an effective prevention strategy, few studies have examined PrEP uptake and adherence in China. This study examined PrEP initiation and adherence among Chinese MSM enrolled in a multi-site PrEP demonstration trial. Methods: Three-month data for this study were drawn from a PrEP demonstration project in Guangzhou and Wuhan, China. The project aimed to increase the engagement of MSM in China for HIV/STI screening, HIV risk reduction, and PrEP initiation and adherence through the use of a mobile phone app and community engagement with crowdsourcing of messages and study images. Part of the intervention was the provision of tenofovir/emtricitabine as PrEP through two types of modalities: (1) once-daily oral dose (Daily-PrEP), or (2) event-driven dose (i.e. the 2 + 1 + 1 approach, Event-Driven PrEP). The outcome of interest was PrEP adherence, defined as missing fewer than five pills in the past 30 days for Daily PrEP, and no missed doses for the Event-Driven PrEP regimen. Univariate and multivariate logistic regressions were conducted for data analyses. Results: A total of 927 individuals started PrEP, with follow-up data available for 650 people (70%) after 3 months. There were 593 men with a median age of 30 years (range 21–61 years) in this study. Of those people, 341 reported taking Daily-PrEP, and 93% (317/341) reported missing fewer than five pills in the past 30 days. Among 252 participants who reported taking the Event-Driven PrEP regimen, 61.5% (155/252) reported full adherence. Daily-PrEP users were more likely to report good adherence than Event-Driven PrEP users (OR 7.28, P < 0.0001, 95% CI: 4.28–12.39). Conclusion: We observed a higher adherence to daily PrEP compared with Event-Driven PrEP among a sample of MSM in China. Further research is needed to examine long-term PrEP adherence among MSM in China.

Original languageEnglish
JournalSexual Health
Volume23
Issue number1
DOIs
Publication statusPublished - 5 Feb 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • China
  • HIV
  • MSM
  • PrEP
  • adherence
  • daily use
  • event-driven
  • pre-exposure prophylaxis

Cite this